BIOADAPTIVES INC vs. Microsoft Corporation
BIOADAPTIVES INC and Microsoft Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BDPT | MSFT | |
|---|---|---|
| Market Cap | — | $3.62 trillion |
| Revenue (TTM) | — | $331.84 billion |
| Net Income (TTM) | — | $133.75 billion |
BDPT and MSFT split the size & scale factors evenly.
Valuation
| BDPT | MSFT | |
|---|---|---|
| P/E Ratio | — | 27.85 |
| Price / Book | — | 8.18 |
| Price / Sales | — | 10.91 |
BDPT and MSFT split the valuation factors evenly.
Profitability
| BDPT | MSFT | |
|---|---|---|
| Net Margin | — | 40.31% |
| Return on Equity | — | 30.23% |
BDPT and MSFT split the profitability factors evenly.
Dividend
| BDPT | MSFT | |
|---|---|---|
| Dividend Yield | — | 0.73% |
| Payout Ratio | — | 20.28 |
BDPT and MSFT split the dividend factors evenly.
Risk & Sentiment
| BDPT | MSFT | |
|---|---|---|
| Short Interest | — | 0.54% |
BDPT and MSFT split the risk & sentiment factors evenly.
Dig deeper: BDPT overview, BDPT financials, MSFT overview, MSFT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.